Surgery Partners Inc Net Assets
Surgery Partners Inc net assets. Based on the latest financial reports, Surgery Partners Inc (SGRY) has net assets worth $3.55 Billion USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.95 Billion) and total liabilities ($4.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SGRY net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.55 Billion |
| % of Total Assets | 44.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | 123.93% |
| 10-Year Change | N/A |
| Growth Volatility | 47.68 |
Net Assets of Surgery Partners Inc (2013–2024)
Net assets of Surgery Partners Inc from 2013 to 2024. This chart illustrates how Surgery Partners Inc's net assets have evolved over time, based on quarterly financial data. See Surgery Partners Inc (SGRY) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Surgery Partners Inc (2013–2024)
The table below shows the annual net assets of Surgery Partners Inc from 2013 to 2024. For live market cap and overall valuation, see how much is Surgery Partners Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.64 Billion | +8.13% |
| 2023-12-31 | $3.36 Billion | +2.41% |
| 2022-12-31 | $3.28 Billion | +42.75% |
| 2021-12-31 | $2.30 Billion | +41.67% |
| 2020-12-31 | $1.62 Billion | -4.47% |
| 2019-12-31 | $1.70 Billion | -- |
| 2018-12-31 | $0.00 | -- |
| 2017-12-31 | $0.00 | -- |
| 2016-12-31 | $0.00 | -- |
| 2015-12-31 | $0.00 | -- |
| 2014-12-31 | $222.12 Million | +1645.22% |
| 2013-12-31 | $-14.38 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Surgery Partners Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 57396400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Surgery Partners Inc Net Assets Breakdown (December 2024)
Surgery Partners Inc net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.30 Million | 0.07% |
| Other Comprehensive Income | $4.80 Million | 0.27% |
| Other Components | $2.52 Billion | 140.86% |
| Total Equity | $1.79 Billion | 100.00% |
Surgery Partners Inc Competitors by Market Cap
The table below lists competitors of Surgery Partners Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BeiJing DaHao Technology Co Lt
SHG:603025
|
$2.00 Billion |
|
Visteon Corp
NASDAQ:VC
|
$2.00 Billion |
|
Karooooo Ltd
NASDAQ:KARO
|
$2.00 Billion |
|
MVV Energie AG
F:MVV1
|
$2.00 Billion |
|
Olin Corporation
NYSE:OLN
|
$2.00 Billion |
|
Glodon Software Co Ltd
SHE:002410
|
$2.00 Billion |
|
Jiangsu Leili Motor Corp Ltd
SHE:300660
|
$2.00 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
$2.00 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Surgery Partners Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,987,200,000 to 1,789,700,000, a change of -197,500,000 (-9.9%).
- Net loss of 168,100,000 reduced equity.
- Other comprehensive income decreased equity by 52,700,000.
- Other factors increased equity by 23,300,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-168.10 Million | -9.39% |
| Other Comprehensive Income | $-52.70 Million | -2.94% |
| Other Changes | $23.30 Million | +1.3% |
| Total Change | $- | -9.94% |
Book Value vs Market Value Analysis
This analysis compares Surgery Partners Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-2.15 | $23.21 | x |
| 2014-12-31 | $-5.48 | $23.21 | x |
| 2015-12-31 | $-0.11 | $23.21 | x |
| 2016-12-31 | $0.20 | $23.21 | x |
| 2017-12-31 | $13.36 | $23.21 | x |
| 2018-12-31 | $8.43 | $23.21 | x |
| 2019-12-31 | $14.33 | $23.21 | x |
| 2020-12-31 | $11.28 | $23.21 | x |
| 2021-12-31 | $15.04 | $23.21 | x |
| 2022-12-31 | $21.73 | $23.21 | x |
| 2023-12-31 | $15.82 | $23.21 | x |
| 2024-12-31 | $14.19 | $23.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Surgery Partners Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.40%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 4.41x
- Recent ROE (-9.39%) is below the historical average (-1.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -3.18% | 0.60x | 0.00x | $1.30 Million |
| 2014 | 0.00% | -16.34% | 0.22x | 0.00x | $-39.49 Million |
| 2015 | 0.00% | 0.15% | 0.46x | 0.00x | $1.83 Million |
| 2016 | 97.69% | 0.83% | 0.50x | 238.19x | $8.49 Million |
| 2017 | -8.09% | -3.95% | 0.29x | 7.06x | $-118.46 Million |
| 2018 | -50.84% | -11.61% | 0.38x | 11.56x | $-246.17 Million |
| 2019 | -10.81% | -4.08% | 0.36x | 7.25x | $-143.98 Million |
| 2020 | -21.11% | -6.24% | 0.34x | 9.84x | $-171.11 Million |
| 2021 | -6.51% | -3.19% | 0.36x | 5.62x | $-179.80 Million |
| 2022 | -2.73% | -2.15% | 0.38x | 3.34x | $-254.42 Million |
| 2023 | -0.60% | -0.43% | 0.40x | 3.46x | $-210.62 Million |
| 2024 | -9.39% | -5.40% | 0.39x | 4.41x | $-347.07 Million |
Industry Comparison
This section compares Surgery Partners Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $463,282,600
- Average return on equity (ROE) among peers: 3.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Surgery Partners Inc (SGRY) | $3.55 Billion | 0.00% | 1.24x | $2.00 Billion |
| Acadia Healthcare Company Inc (ACHC) | $2.17 Billion | 0.28% | 1.78x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $158.93 Million | 7.57% | 0.45x | $1.69 Billion |
| agilon health Inc (AGL) | $-232.03 Million | 0.00% | 0.00x | $1.43 Billion |
| Airsculpt Technologies Inc (AIRS) | $70.77 Million | -20.74% | 1.84x | $124.72 Million |
| Amedisys Inc (AMED) | $397.76 Million | 3.21% | 0.68x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $108.01 Million | -3.68% | 3.35x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $1.66 Billion |
| Astrana Health Inc (ASTH) | $510.64 Million | 13.50% | 0.70x | $1.81 Billion |
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers … Read more